Clinical Investigation Specialists

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Obesity1 trial
• Peripheral artery disease1 trial
• Sjögren's disease1 trial
• Stroke1 trial
• Type 1 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

  NCT04968912· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Eli Lilly and Company· Source